CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
01 août 2018 08h45 HE | CV Sciences, Inc.
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 MillionManagement to Host Second Quarter 2018 Financial Results Conference Call on August...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Host Annual Meeting of Shareholders and Investor Day on August 4, 2018 in San Diego, California
10 juil. 2018 08h45 HE | CV Sciences, Inc.
Company to Feature Guest Speaker, World-Renowned Neurosurgeon and Sports Medicine Expert Dr. Joseph Maroon LAS VEGAS, July 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Issues Letter to Shareholders
27 juin 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the industry-dominating brand...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of Base Material of its PlusCBD Oil™ Products
15 juin 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, June 15, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today the June 7, 2018 publication of the toxicology and safety...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Settles SEC Matter
01 juin 2018 08h45 HE | CV Sciences, Inc.
The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Supports World No Tobacco Day on May 31, 2018
31 mai 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, May 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), is pleased to announce its support in highlighting the World Health...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
22 mai 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018
08 mai 2018 05h45 HE | CV Sciences, Inc.
LAS VEGAS, May 08, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) a preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Fully Retires Convertible Debt
25 avr. 2018 11h08 HE | CV Sciences, Inc.
Company Fully Repays Outstanding Convertible Debt and Avoids Dilution to Stockholders LAS VEGAS, April 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,”...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - April 29-May 2, 2018
18 avr. 2018 08h45 HE | CV Sciences, Inc.
Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE...